Recent Quarter Total Invested
$341,019
Recent Quarter Institutional Ownership Percentage
11.63%
Total Invested of Last Quarter
$7.35 M
Ownership Percentage of Last Quarter
71.99%
Impel Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VENBIO PARTNERS LLC | 02/14/2024 | 2.76 M | $340,834 | 0.00% | 11.62% |
| ST GERMAIN D J CO INC | 01/02/2024 | 1,500 | $185 | 0.00% | 0.01% |
| JPMORGAN CHASE & CO | 02/12/2024 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/09/2024 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 03/11/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 08/16/2024 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 01/16/2024 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| LASRY MARC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| MCDONALD PARTNERS LLC | 02/12/2024 | 0 | $0 | -100.00% | 0.00% |
| BRIGHTON JONES LLC | 02/05/2024 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 01/29/2024 | 0 | $0 | -100.00% | 0.00% |
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/26/2024 | 0 | $0 | -100.00% | 0.00% |
| NVP ASSOCIATES, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/09/2024 | 0 | $0 | -100.00% | 0.00% |
| VIVO CAPITAL, LLC | 02/07/2024 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/12/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| LINDBROOK CAPITAL, LLC | 02/01/2024 | 0 | $0 | -100.00% | 0.00% |
| EPIQ PARTNERS, LLC | 01/11/2024 | 0 | $0 | -100.00% | 0.00% |
| 5AM VENTURE MANAGEMENT, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| DCF ADVISERS, LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
Impel Pharmaceuticals Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IMPL shares?
During the previous two years, 4 institutional investors and hedge funds held shares of Impel Pharmaceuticals Inc.. The most heavily invested institutionals were:
TRUSTCORE FINANCIAL SERVICES, LLC: 14,407
Amalgamated Financial Corp.: 839
Norwest Venture Partners XIV, LP: 3.08 M
Berman Capital Advisors, LLC: 397
-
What percentage of Impel Pharmaceuticals Inc. stock is owned by institutional investors?
11.63% of Impel Pharmaceuticals Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at IMPL ?
Institutional investors have bought a total of 3.09 M shares in the last 24 months. This purchase volume represents approximately $123,714 in transactions.